Equity Strategies Group-Level Analysis Of The Equity Markets

Looking for Q4 tactical trading opportunities in Tech.

• Read more

The strong relative performance in Industrial Metals shares over the past four months provides evidence that investors are beginning to buy into the sustainability of the current uptrend in metals prices.

• Read more

Based on oil futures prices, 2005 year-end  consensus  earnings forecasts for the Integrated Oil & Gas group appear too low! These too-low forecasts imply further upside for oil shares, and, at the very least, limited downside relative to the rest of the market.

• Read more

Health Care was our top-ranked sector from March 2003 to February 2004. Since that time, the sector’s composite score has steadily fallen. 

• Read more

The strong relative performance in Industrial Metals shares over the past three months leads us to believe that investors are beginning to buy into the sustainability of the current uptrend in metals prices.

• Read more

The near term is becoming more uncertain for Health Care stocks, as HC groups have experienced an erosion in GS Score strength.

• Read more

The Industrial Metals group, our second largest Select Industries portfolio group holding, continued to rally in June.

• Read more

We view Health Care as a key theme in 2004. The sector is defensive and sports high growth rates thanks to the large (and growing) demand from elderly Americans.

• Read more

Industrial Metals group had nice rally after big decline in April. Early May increase in this portfolio group holding was very timely.

• Read more

We see Health Care as a key theme in 2004. The sector is defensive, but sports high growth rates– hitting an investment “sweet spot”, which should allow for strong relative performance in any market environment.

• Read more

Making first Financial sector purchase since 2001, buying Life & Health Insurance. On a  selected basis, there are pockets of attractive Financial groups, but we still advise being underweight this sector.

• Read more

Small and Mid Caps stumbled hard in a brutal month of trading and the major indices didn’t do much better. In March, we noted the lack of strong sector trends among the best and worst performing groups. This definitely reversed in April.

• Read more

There was a brief pause last month in our Health Care scores, and we were proceeding with caution. This month, our GS Score work regained some of that lost momentum.

• Read more

REITs and Financials still unattractive despite retreating in April. Financial sector weight in S&P 500 still too high given the interest rate climate.

• Read more

Over the last few years, we have been employing a beta adjusted relative strength calculation for high beta groups, along with the traditional relative strength. There are often more revealing signals given by the beta adjusted relative strength, especially in recent years.

• Read more

This month, we thought it may be interesting to revisit the Nanotechnology group, which has continued to attract a high level of interest from investors and speculators alike.

• Read more

Small and Mid Caps continued to outperform in March, with the S&P Small and Mid Cap both producing positive returns.

• Read more

Since 2000, the Health Care sector has moved ahead with no help from the big drug stocks.

• Read more

Investors reversed course from January with several of last month’s top performers becoming February’s worst performers.

• Read more

This value-oriented quantitative group has been rated Attractive for three consecutive months. Value, Technical, Judgmental and Insiders categories all contributing to current GS Score strength.

• Read more